Mikhail Blagosklonny and his Successful Career

Mikhail Blagoslonny is considered to be one of the most successful professionals in cancer and research industry. At the moment, the successful scientist is serving as the professor of oncology at the prestigious Roswell Park Cancer Institute. At the institution, Mikhail is responsible for several activities. First of all, he carries out extensive research, especially on matters concerning aging and cancer. These are some of the most valuable lessons in the modern times. Mikhail is based in New York City, and he has worked hard to change the lives of many people who are living with the cancer disease. The successful professor has a rich educational background, and this is one of the reasons he has done so well in his career.

Since childhood, Mikhail was a bright student who wanted to make a successful career. His parents were middle-class individuals who wanted their son to have the best life. This is why they sacrificed their income to take him to some of the best schools in the world. Mikhail went for his doctorate at a prestigious learning institution because he wanted to sharpen his skills, especially in the field department. Mikhail specialized in medicine and cardiology, and he graduated with first class honors. His exceptional performance at school impressed everyone and more information click here.

After completing his doctorate education, Mikhail was given an opportunity to work in some of the teaching institutions in the country. At first, he went to the New York Medical College where the management felt that he was going to perform best while serving as an associate professor in the medicine department. Mikhail worked in this institution for a while until he decided to move to Ordway Research Institute in the year 2002. At the research center, Mikhail served at the position of senior scientist. Later on, the successful scientist left the organization to work at the Roswell Park Cancer Institute where he serves up to date.

While serving at the institution, Mikhail has impacted the lives of so many people, especially those who are looking for knowledge. His publications are used in almost all the cancer research centers in the world. Apart from being a successful cancer specialist who is doing his best to get an effective treatment for cancer, Mikhail is the chief editor for one of the most respected scientific journals in the world.The journal is called Oncotarget, and it is published by professionals who understand the research field well and what Dr. Mikhail knows.

As the editor of the journal, Mikhail has done his best to make sure that people from all walks of life get the valuable information they need first. Before the content is published for the public, the professors at the institution take time to check it so that the quality of the information is not compromised. The journal has done well in the market, and it has many followers who want to acquire information. Just recently, Oncotarget published about the effects of electronic cigars among the young people. Before the content was published, many people did not know the harm they were causing to themselves and Mikhail’s lacrosse camp.

More Visit: http://www.aging-us.com/article/100591

The Process Dr. Avi Weisfogel Took to Develop Better Treatments for Sleep Apnea

Sleep apnea is a condition experienced by many people around the world. People with this condition do not receive a full night’s sleep, because their air passageway prevents them from breathing correctly. This in turn, prevents them from experiencing REM sleep. Lack of sleep could contribute to everything from an unsightly appearance to impaired thinking. Dr. Avi Weisfogel has taken an interest in the effects and causes of sleep apnea. This interest led him to create a facility known as Dental Sleep Masters in order to bring more information about sleep apnea to the medical community. As a practicing dentist, Dr. Weisfogel has become very familiar with many of the physical indications for sleep apnea, which could include loss of hair, pooling of blood beneath the eyes and a dulled complexion.

Dr. Avi Weisfogel has spent more than 25 years as a practicing dentist in the New Jersey area. During this time he created several organizations and companies designed specifically to help find more effective treatments for sleeping disorders. One of the first companies Dr. Weisfogel founded was Healthy Heart Sleep. This company was established as a way to connect with other professionals in the fields of medicine and dentistry to help create better management systems for sleep disorders such as sleep apnea. This also became a means through which Dr. Weisfogel could collaborate with others about his own ideas for the treatment of sleep apnea. Two years after launching Health Heart Sleep, Dr. Weisfogel created Owner Unlimited Sleep Patient as a medium through which he could provide lectures to other dentists on how to best serve patients with sleep apnea.

In addition to the qualifications Dr. Avi Weisfogel has as an experienced dentist, he also holds a Bachelor’s degree in biology and psychology, which he obtained from Rutgers University. Along with the work he has done to help improve the treatment of sleep apnea, Dr. Weisfogel has also taken an interest in helping children from impoverished countries receive better oral care. In an effort to assist Operation Smile with the surgeries they perform, he established a Go Fund Me campaign to help raise money to support their efforts.

The Importance of Life Line Screening

Life Line Screening is the process of accessing the condition of one’s body to make sure the body is kept in the best state possible. The Life Line Screening helps to identify the tests that are most important, and that will benefit a particular individual depending on their age, medical history, family history and the general state of the body. Each is different from the other and have their health risk factors. While everyone benefits from screening, some tests are more beneficial to certain individuals than others. There are some tests that can be done through screening to identify the presence of chronic diseases.

According to the US Center for Disease Control and Prevention, there are millions of people who die yearly as a result of some of the diseases that are preventable if detected on time. While disease and death are inevitable, modern medicine has provided a wide range of tools and knowledge on dealing with some chronic health issues. Preventive health care which includes tests like blood tests, ultrasounds and other organ tests is a proven way of detecting the chronic diseases to start using the relevant medication in good time.

There are many benefits associated with preventive healthcare. Just like a car is taken to a mechanic even when it is still moving to check on oil and the general state of the car, the human body also needs to check up. The proactive approach to health helps prevent more serious and costly health conditions. The disease can be detected early before the body begins to show signs and symptoms of sickness. Other times some disease may be detected and dealt with before they develop. Other times you may be assisted to make some lifestyle adjustments to prevent the occurrence of chronic or terminal illnesses and learn more about Life Line Screening.

Screening offers access to some simple but potent tools to help detect the current or future health risks. The individual is given an opportunity prevent certain health conditions before the real sickness strikes. Life Line screening can provide tests that measure testosterone, liver enzymes, cholesterol, blood pressure, Diabetes, cardiovascular systems among others and read full article.

More Visit: http://www.lifelinescreening.com/Global/Employee-Access

What you ought to know about Amicus Therapeutics

In today’s world, the health sector is among the few areas experiencing an incredible but crucial growth. Owing to the rise in cases of ailments triggered by the lifestyle changes, various institutions have made it their daily mandate to implement new treatment means. Amicus Therapeutics, Inc. is among the few but notable companies setting their foot forward in the biotechnology sector precisely.

 

Globally, the company is known for the uncovering, developing and marketing of acute treatments for devastating genetic diseases. Amicus was founded back in 2002 and has its headquarters in Cranbury, New Jersey. Today, the company stands as a public entity under FOLD, NASDAQ’s trading symbol. Before, the successful business was funded by distinguished firms such as Radius Ventures, Canaan Partners, and New Enterprise Associates among others.

 

Amicus Therapeutics specializes in products broadly based on the Chaperone-Advanced Replacement Therapy platform. With time, the company has been keen on the development of enzyme replacement therapies. One of its important products includes migalastat HCl, a product that can be used for the treatment of fabry diseases when mixed with enzyme replacements. Also, migalastat can be used as a monotherapy.

https://twitter.com/amicusrx1?lang=en

Back in 2014, Amicus Therapeutics was named as the best developer of small molecule pharmacological chaperones. However, earlier the same year, the company had no marketed products even with migalastat (Galafold) in place. Practically, Amicus has no manufacturing abilities hence rely on contract manufacturing solo. However, the company own a research site based in San Diego that was established in 2008.

 

Every successful business’s story is characterized by ups and downs, and Amicus is no ordinary. For example, in 2009, the company was hit by a major financial setback due to the termination of a multi-year partnership agreement with Shire (YahooFinance). Later, the company received funding from various foundations to support its researchers.

 

Within time, Amicus Therapeutics has acquired various competitive companies such as Callidus Biopharma and Scioderm. Today, John Crowley serves as the company’s CEO, a position that he has held since 2005. Bradley Campbell serves as the company’s COO while William D. Baird III assists as the chief financial officer. Last but not least on the company’s executive team is David Lockhart who serves as the chief scientific officer, the heart of the business.

More of Amicus Therapeutics on